ZyVersa Therapeutics Inc [NASDAQ: ZVSA] traded at a high on Monday, posting a 15.63 gain after which it closed the day’ session at $5.77.
The results of the trading session contributed to over 8047956 shares changing hands. Over the past one week, the price volatility of ZyVersa Therapeutics Inc stands at 19.33% while the volatility over the past one month is 11.25%.
The market cap for ZVSA stock reached $4.39 million, with 0.41 million shares outstanding. Compared to the average trading volume of 253.58K shares, ZVSA reached a trading volume of 8047956 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about ZyVersa Therapeutics Inc [ZVSA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZVSA shares is $80.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZVSA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for ZyVersa Therapeutics Inc is set at 0.88 The Price to Book ratio for the last quarter was 0.21, with the Price to Cash per share for the same quarter was set at 4.13.
How has ZVSA stock performed recently?
ZyVersa Therapeutics Inc [ZVSA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.38. With this latest performance, ZVSA shares dropped by -23.07% in over the last four-week period, additionally sinking by -85.73% over the last 6 months – not to mention a drop of -96.72% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZVSA stock in for the last two-week period is set at 41.26, with the RSI for the last a single of trading hit 42.29, and the three-weeks RSI is set at 41.59 for ZyVersa Therapeutics Inc [ZVSA]. The present Moving Average for the last 50 days of trading for this stock 7.60, while it was recorded at 5.71 for the last single week of trading, and 27.04 for the last 200 days.
ZyVersa Therapeutics Inc [ZVSA]: Deeper insight into the fundamentals
ZyVersa Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.33 and a Current Ratio set at 0.33.
Insider trade positions for ZyVersa Therapeutics Inc [ZVSA]
The top three institutional holders of ZVSA stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in ZVSA stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in ZVSA stock with ownership which is approximately 5.8386%.
